April 2023

Contents

Editorial

• HTB April 2023 (6 April 2023)

Conference reports

• 30th CROI (CROI 2023): further reports

• Dapivirine ring safe in late pregnancy and during breastfeeding

• Implications of restrictions on reproductive rights for HIV care in the USA and beyond

Antiretrovirals

• Generic versions of injectable PrEP could enable access to CAB-LA in low-income countries

mpox (monkeypox)

• UK data on efficacy of mpox vaccine: caution needed in observational analyses 

• Updates on US mpox research: surveillance, testing, vaccines and research

• Cases of mpox reinfection in HIV negative men on PrEP: atovaquone, mefloquine and molnupiravir as potential treatments

Coinfections and complications

• Statins reduce heart disease by 35% in the international HIV REPRIEVE study

• Penile BOTOX injections improve blood flow and other outcomes in men with moderate to severe erectile dysfunction

Cure-related research

• HIV cures 3, 4 and 5: Düsseldorf case published, City of Hope patient gives public interview, New York case published

Drug resistance

• IAS-USA update HIV drug resistance tables

Treatment advocacy

• David Wojnarowicz: F**k You F*ggot F**ker – now online

On the web

• Long-term survivors & HIV cure research

• Training webinar: 2nd HIV from A to Z

PDFs

• HTB: no. 4 (April 2023) PDF download